Your browser doesn't support javascript.
loading
lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway.
Kang, Haijun; Huang, Dongmei; Li, Heng; Deng, Xuejun; Liu, Siyuan; Gou, Wenjun; Liu, Linglin; Qiu, Yuyan; Yang, Xu.
Afiliação
  • Kang H; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
  • Huang D; Department of Cardiovascular, Suining Central Hospital, Suining, Sichuan, China.
  • Li H; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
  • Deng X; Department of Cardiovascular, Suining Central Hospital, Suining, Sichuan, China.
  • Liu S; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
  • Gou W; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
  • Liu L; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
  • Qiu Y; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
  • Yang X; Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan, China.
Bioengineered ; 13(7-12): 15003-15012, 2022.
Article em En | MEDLINE | ID: mdl-37105761

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinopatia Hipertensiva / Fosfatidilinositol 3-Quinase Limite: Humans Idioma: En Revista: Bioengineered Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinopatia Hipertensiva / Fosfatidilinositol 3-Quinase Limite: Humans Idioma: En Revista: Bioengineered Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China